Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

R2: Finding the Needle in Radiology's Haystack

Executive Summary

Over the past decade or so, the means of producing diagnostic images have improved greatly, but the technology for reading them has failed to keep pace. Radiologists read new computerized images with hand-held magnifying glasses, calipers and rulers, the same tools used for years. R2 Technology, by providing radiologists with better means of reading images through computer-aided detection software, is looking to carve out a niche in the diagnostic imaging market, where few small companies have ventured successfully. R2 is the first-to-market with FDA-approved CAD technology for breast cancer screening, and plans to develop this as a platform technology for other cancers, betting that its first-mover advantage helps establish the industry standard.

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

IV001555

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel